FDA delays approval of GSK bird flu vaccine
LONDON (Reuters) - Regulators have delayed approval of an H5N1 bird flu vaccine from GlaxoSmithKline, designed to be used in a pandemic.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news